In one experimental NASH model in mice, LCN2 upregulation was found in hepatic parenchymal cells positioned next to inflammatory cell clusters, making LCN2 a putative NASH marker. Here, LCN2 is linked to metabolic dysfunction-associated steatohepatitis.